Claim802fdc1d1c88f87c3403bf2babd254ee7078d5f398e8242446fc7af743a4fb15·My Arguments

A 2024 network meta-analysis of 29 double-blind RCTs found that several SSRIs (paroxetine, fluoxetine, escitalopram) reduced suicidal ideation relative to placebo at week 2, but this protective effect diminished by week 8, and no SSRI showed a significant difference from placebo on actual suicidal behavior across weeks 1-10.

Evidence (1)

Effects of selective serotonin reuptake inhibitors (SSRIs) on suicide: A network meta-analysis of double-blind randomized trials
Network meta-analysis showing short-term ideation protection but no behavioral risk reduction versus placebo.
https://pubmed.ncbi.nlm.nih.gov/38663222/

Respond to this claim on Isonomia

Build or challenge arguments with structured reasoning in the Digital Agora.

Join & respond

Embed this claim

<iframe
  src="https://www.isonomia.app/embed/claim/802fdc1d1c88f87c3403bf2babd254ee7078d5f398e8242446fc7af743a4fb15"
  width="600"
  height="280"
  frameborder="0"
  style="border: 1px solid #e5e7eb; border-radius: 8px;"
  title="Isonomia Claim"
  loading="lazy"
></iframe>

Copy and paste into any website or forum that supports HTML.